Glatiramer and injection site induration Patient Reports February 11, 2012

Glatiramer Side Effects Report #4686120-5
Glatiramer side effect was reported by a Consumer or non-health professional from on May 25, 2005. Male patient, 55 years of age, was diagnosed with multiple sclerosis  and was treated with Glatiramer. After drug was administered, patient experienced the following side effects: injection site discolouration, injection site erythema, injection site haemorrhage, injection site induration, injection site necrosis, injection site oedema, injection site pain, lividity, scar . Glatiramer dosage: 20 MILLIGRAM, SUBCUTANEOUS. During the same period patient was treated with ASPIRIN, GINKGO TREE LEAVES, TESTOSTERONE. Patient recovered.

Glatiramer Side Effects Report #4968067-X
Glatiramer side effect was reported by a Consumer or non-health professional from GERMANY on Mar 25, 2006. Female patient, 48 years of age, was diagnosed with multiple sclerosis  and was treated with Glatiramer. After drug was administered, patient experienced the following side effects: cutaneous vasculitis, eosinophilia, injection site induration, injection site necrosis, injection site reaction, panniculitis, skin haemorrhage. Glatiramer dosage: 20 MILLIGRAM SUBCUTANEOUS. Patient recovered.

Glatiramer Side Effects Report #4560765-5
Glatiramer side effect was reported by a Consumer or non-health professional from on Jan 17, 2005. Female patient, 28 years of age, was diagnosed with multiple sclerosis  and was treated with Glatiramer. After drug was administered, patient experienced the following side effects: injection site induration, injection site necrosis. Glatiramer dosage: 20 MILLIGRAM SUBCUTANEOUS. Patient recovered.

Glatiramer Side Effects Report #5044591-9
Glatiramer side effect was reported by a Consumer or non-health professional from SPAIN on June 23, 2006. Male patient, 28 years of age, was diagnosed with multiple sclerosis  and was treated with Glatiramer. After drug was administered, patient experienced the following side effects: embolia cutis medicamentosa, injection site induration, injection site necrosis. Glatiramer dosage: 20 MILLIGRAM, SUBCUTANEOUS. Patient recovered.